trending Market Intelligence /marketintelligence/en/news-insights/trending/3ltv3rk6kcpwaizc9jpdkw2 content esgSubNav
In This List

Editas Medicine names board member

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise


Editas Medicine names board member

Mass.-based biotech company Editas Medicine Inc. appointed Jessica Hopfield as a board member.

Hopfield is the chairperson of the board for Joslin Diabetes Center and serves as the lead independent director on the board at Insulet Corp.